Inhibrx, Inc. (INBX) Financials
INBX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 307.9 million | 264.4 million |
2023-09-30 | 372.7 million | 243.1 million |
2023-06-30 | 213.2 million | 238.0 million |
2023-03-31 | 253.7 million | 238.6 million |
INBX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -60.3 million | 6.4 million |
2023-09-30 | -55.1 million | 6.5 million |
2023-06-30 | -42.6 million | 6.3 million |
2023-03-31 | -40.0 million | 5.6 million |
INBX Net Income
No data available :(
INBX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 277.9 million | - | 3.2 million |
2023-09-30 | 337.3 million | - | 3.7 million |
2023-06-30 | 192.5 million | 204.5 million | 4.1 million |
2023-03-31 | 234.3 million | 203.3 million | 4.6 million |
INBX Shares Outstanding
INBX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.4 million | 81.8 million | 7.8 million | 46000 |
2023-09-30 | 811000 | 38.1 million | 7.9 million | - |
2023-06-30 | 317000 | 34.1 million | 7.3 million | - |
2023-03-31 | 23000 | 37.4 million | 6.4 million | - |
INBX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.6 million | 298000 |
2023-09-30 | 119000 | 304000 |
2023-06-30 | 30000 | 731000 |
2023-03-31 | 17000 | 722000 |
INBX
Price: $34.01
52 week price:
Earnings Per Share: -5.12 USD
P/E Ratio: -8.80
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 275430
Market Capitalization: 1.7 billion